Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England

Aamir Khakwani,Neal Navani,Doug West,David Baldwin,Richard Hubbard,Susan Harden,Paul Beckett

doi:10.1136/thoraxjnl-2018-212493

Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England

Aamir Khakwani, Neal Navani + Show 5 more

https://doi.org/10.1136/thoraxjnl-2018-212493

Copy DOI

Journal: Thorax	Publication Date: Dec 26, 2019
Citations: 17

Affiliation: University of Nottingham, Royal London Hospital, University College London, University Hospitals Bristol NHS Foundation Trust, Nottingham University Hospitals NHS Trust, Cambridge University Hospitals NHS Foundation Trust, Royal Derby Hospital

#Stereotactic Ablative Radiotherapy #National Lung Cancer Audit Database + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BackgroundApproximately 15%–20% of all non-small cell lung cancer (NSCLC) cases present with stage I disease. Surgical resection traditionally offers the best chance of a cure but some patients will not...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Thorax

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.